Sharepoint Solutions

PRODUCTS

  • Currently in use for biological research involving infectious agents this mobile BSL-3 biocontainment lab was delivered in November 2020. It is a self contained Mobile BSL3 Laboratory with engineering controls that protect personnel while isolating infectious agents. This facility was built for continuous use in the cold climate of the northeast United States without a shell building.

  • Our research is powered by MRN owned, regulatory-approved and validated eClinical software systems. Our technology can be used at-site and at-home enabling fully integrated data through any clinical trial.

  • Once the unique properties of your drug substance are assessed, one of Mikart’s formulation experts is assigned to your project to determine complementary excipients.

  • Code and approve clinical trial data from any device and keep your safety and efficacy data clean, consistent, and ready for analysis.

  • With Autodesk InfoWorks WS Pro, engineers can accurately model water distribution systems.

WHITE PAPERS AND CASE STUDIES

NEWS

  • Rapeseed Protein For Vegan Burger Patties And Nutritious Chicken Feed
    8/13/2025

    Food products containing proteins from plants, fungi or algae are becoming increasingly popular. Researchers at the Fraunhofer Center for Chemical-Biotechnological Processes CBP in Leuna, Germany, have now shown that previously rarely used rapeseed proteins are also a valuable source of protein alternatives: using the EthaNa process, they extract not only high-quality rapeseed oil from rapeseed but also a protein-rich rapeseed kernel concentrate, which can be processed for instance into burger patties and pasta or used as a nutritious feed in poultry fattening.

  • Higgins, Timmons Introduce Legislation To Repeal EPA Rule On Chemical Manufacturing
    3/11/2025

    Congressman Clay Higgins (R-LA) and Congressman William Timmons (R-SC) introduced legislation to repeal the U.S. Environmental Protection Agency’s (EPA) final procedural rule for new chemical reviews under the Toxic Substances Control Act (TSCA).

  • Pittsburgh Water Receives $26M In Grants And Low-Interest Loans From PENNVEST
    1/23/2025

    Today, Pittsburgh Water announced the receipt of $26M in grants and low-interest loans from the Pennsylvania Infrastructure Investment Authority (PENNVEST) to continue the diligent removal of lead service lines throughout Pittsburgh’s drinking water system.

  • Egetis Therapeutics Initiates New Drug Application In The USA For Emcitate (Tiratricol) For MCT8 Deficiency
    12/19/2025

    Egetis Therapeutics AB (publ) (“Egetis” or the “Company”), today announced that the Company has initiated a rolling New Drug Application (NDA) submission to the U.S. Food and Drug Administration (FDA) for Emcitate (tiratricol), its investigational drug for the treatment of MCT8 deficiency.

  • Investigating The 'Glue' That Holds Cells Together
    3/20/2025

    Northwestern Medicine investigators have uncovered new insights into how intercellular “glue” functions to enable interactions between cells, as detailed in a study published in Nature Communications.